Indian equities do not trade at one common valuation level. Different parts of the market carry very different prices relative to their expected earnings growth and their own past valuation levels.
This gap matters because a high valuation does not, by itself, show that an equity is expensive or that its future return will be weak. A high multiple can reflect stronger expected earnings growth, better earnings visibility, a longer growth runway, or a combination of these factors. At the same time, a low multiple does not automatically mean that an equity is cheap. A lower price can reflect weaker growth, greater uncertainty, or a higher risk of an earnings shortfall.
A useful way to study the Indian market, therefore, is to ask where investors pay the largest premium for expected growth.
Recent valuation data show a clear divide. Healthcare, defence, selected capital goods, infrastructure and parts of the energy sector carry relatively high valuations. In contrast, information technology, banks and some real estate stocks trade at much lower valuations than their own long-term averages.
The data also show a notable gap between large companies and the broader mid-cap and small-cap segments.
Healthcare carries one of the largest premiums
Healthcare stands out as one of the clearest examples of a sector where investors have accepted a substantial valuation premium.
As of June 2026, the Nifty Healthcare index traded at about 33.1 times forward earnings. Its 10-year average was about 16.7 times. On that measure, the current level represented a premium of about 98% over the long-term average.
This does not mean that healthcare stocks must fall, nor does it establish that the sector is overvalued. It shows that the market places a much higher earnings multiple on the sector than it has on average over the past decade.
The reason for that premium can be linked to expectations of structural demand and earnings growth. The healthcare universe includes hospitals, diagnostics, pharmaceutical companies and other businesses that can benefit from higher healthcare expenditure and changes in treatment demand.
The valuation question is therefore important. When a sector trades at almost twice its historical average multiple, future earnings may need to rise at a strong pace for that valuation to remain supported.
Defence also has a large growth premium
Defence is another part of the market where valuations reflect strong expectations.
The June 2026 data showed the defence sector at about 24% above its long-term valuation average. This premium reflects expectations linked to defence orders, domestic manufacturing, import substitution and possible export opportunities.
The underlying business case can be strong, but the market valuation already reflects part of that expectation. Investors who assess such companies may therefore need to consider not only whether earnings can grow, but also whether the actual pace of growth can match the assumptions that the current valuation may imply.
That distinction is important. A company can report good earnings growth and still see its valuation multiple decline if the market had expected an even higher rate of growth.
Other sectors with clear valuation premiums
The same June 2026 data showed a premium of about 26% for pharmaceuticals, 22% for energy and 17% for infrastructure relative to their respective long-term valuation averages.
These sectors have different business models and different earnings drivers, so their premiums should not be treated as directly comparable.
Pharmaceutical valuations can reflect product pipelines, export opportunities, specialty drugs and changes in healthcare demand. Energy valuations can reflect power demand, capacity additions and related infrastructure. Infrastructure valuations can reflect capital expenditure, order books and public as well as private investment.
The common feature is that the market has assigned these areas a valuation above their historical norms.
Sector valuation comparison
| Sector | Forward valuation / historical measure | Premium or discount |
|---|---|---|
| Healthcare | 33.1× forward earnings | About 98% above 10-year average |
| Pharmaceuticals | — | About 26% above long-term average |
| Defence | — | About 24% above long-term average |
| Energy | — | About 22% above long-term average |
| Infrastructure | — | About 17% above long-term average |
| IT | 16.3× forward earnings | About 28% below 10-year average |
| Financial services | — | About 22% below long-term average |
| Banks | — | About 23% below long-term average |
The table gives a useful view of the dispersion. The market is not simply expensive across the board. Some sectors carry large premiums, while others trade at meaningful discounts to their own historical levels.
Small caps present a different valuation picture
Market capitalisation adds another layer to the analysis.
Motilal Oswal’s February 2026 data placed the forward price-to-earnings ratio of the Nifty 50 at 20.2 times, the Nifty Midcap 100 at 26.9 times, and the Nifty Smallcap 100 at 23.2 times.
Their long-period averages were about 20.9 times for the Nifty 50, 23.5 times for the Nifty Midcap 100, and 17 times for the Nifty Smallcap 100.
The comparison shows that large-cap valuations were close to their long-period average. Midcaps had a larger premium. Smallcaps had an even more visible gap against their historical average.
Market-cap valuation comparison
| Index | Forward P/E, Feb. 2026 | Long-period average | Difference |
|---|---|---|---|
| Nifty 50 | 20.2× | 20.9× | Below average |
| Nifty Midcap 100 | 26.9× | 23.5× | Above average |
| Nifty Smallcap 100 | 23.2× | 17.0× | Well above average |
This does not mean that every small-cap company trades at a high valuation. The small-cap category contains a very wide range of businesses, balance sheets and earnings profiles.
It does show that, at the index level, investors have placed a substantial valuation premium on the smaller-company segment.
Growth partly explains the premium
The valuation premium becomes easier to understand when earnings growth is added to the picture.
NSE data for the third quarter of FY26 showed median profit-after-tax growth of 19.1% for the Midcap 150 and 21.8% for the Smallcap 250. The corresponding figure for the Nifty 50 was 10.1%.
This creates an important distinction.
Midcaps and smallcaps had much stronger median profit growth in that period than the Nifty 50. Their higher valuations therefore had at least some fundamental growth support.
However, the figures do not establish that the same growth rate will continue. One quarter of earnings data cannot, by itself, determine a long-term earnings path.
The more useful question is whether future earnings growth can remain high enough to support the current valuation.
The PEG comparison adds another layer
ICICI Direct’s May 2026 analysis gave another way to look at the market. It placed the Nifty 50 at roughly 17 times forward earnings, with expected earnings growth of about 16%.
The Midcap segment stood at about 22 times forward earnings, with expected growth of about 17%.
Smallcaps stood at about 17 times on a two-year-forward basis, with expected earnings growth of about 23%.
ICICI Direct also reported a PEG measure of roughly 0.7 times for smallcaps, compared with about 1.0 times for the Nifty 50 and about 1.3 times for midcaps.
These numbers should be treated with care because the valuation periods and growth assumptions are not identical across every measure. PEG is also highly sensitive to the earnings-growth estimate used in the calculation.
Still, the data show why a simple P/E comparison can give an incomplete picture. A company or index with a higher P/E can have a lower growth-adjusted valuation if its expected earnings growth is sufficiently higher.
Growth and valuation comparison
| Segment | Forward valuation | Expected earnings growth |
|---|---|---|
| Nifty 50 | About 17× | About 16% |
| Midcaps | About 22× | About 17% |
| Smallcaps | About 17× on a two-year-forward basis | About 23% |
The figures suggest that the market has placed a significant premium on the expected earnings growth of smaller companies. Whether that premium proves reasonable depends on the durability and quality of that growth.
Where the largest premium appears
The answer changes depending on the definition of “growth premium”.
If the focus is on the premium to historical valuation, healthcare is one of the clearest examples. Its valuation at 33.1 times forward earnings, compared with a 10-year average of 16.7 times, represents a very large historical gap.
If the focus is on valuation relative to expected earnings growth, the small-cap segment presents a different picture. ICICI Direct’s figures show expected earnings growth of about 23%, against a two-year-forward valuation of about 17 times.
If the focus is on market-cap valuation relative to historical norms, the small-cap segment also has a large premium. Its 23.2 times forward P/E compared with a 17 times long-period average represents a substantial difference.
These are different measures, and they should not be treated as interchangeable.
IT and banks show the other side of the market
Information technology and financials provide a useful contrast.
The June 2026 data placed IT at about 16.3 times forward earnings, roughly 28% below its 10-year average.
Financial services and banks were also below their long-term valuation levels, at about 22% and 23% below their respective averages.
This suggests that the market currently assigns a lower valuation to areas where near-term growth or earnings visibility appears less certain.
For IT, valuation pressure has existed alongside questions about technology demand, artificial intelligence and the pace of recovery in global technology expenditure.
For banks, the valuation picture is different. Lower multiples can reflect the maturity and scale of the sector, credit-cycle conditions, margin expectations and the market’s assessment of future loan and profit growth.
A low valuation, therefore, should not automatically be read as an opportunity. It simply means that investors currently pay less for each unit of expected earnings than they have paid on average in the past.
The central valuation divide
The current Indian equity market can broadly be viewed through two valuation groups.
The first group consists of businesses where investors pay a premium for visible or expected structural growth. Healthcare, defence, selected capital goods, infrastructure and parts of energy fall into this broad category.
The second group consists of businesses where valuations remain more moderate because the market expects slower growth, greater uncertainty or a recovery that is not yet fully visible. IT, banks and some real estate companies fall within this broad group.
This divide helps explain why a statement such as “Indian equities are expensive” can be too broad to be useful.
The Nifty 50 at 20.2 times forward earnings in the February 2026 Motilal Oswal data was close to its long-period average of 20.9 times. At the same time, the Midcap 100 and Smallcap 100 traded at materially higher multiples relative to their own history.
The market therefore had significant internal dispersion.
What the premium requires
A high valuation creates a higher level of dependence on future earnings.
Consider a simple example. If a company trades at a high multiple because investors expect rapid earnings growth, a strong earnings result may not be enough to support the share price if future growth falls below market expectations.
The opposite can also occur. If earnings rise faster than expected, the valuation can remain high even if the multiple itself does not expand.
This is why the key issue is not simply whether a sector has a high P/E. The more useful analysis asks what earnings growth is already reflected in that P/E.
For healthcare, the 33.1 times forward P/E shows a very large valuation premium relative to the historical average. For smallcaps, the 23% expected earnings growth cited by ICICI Direct provides a different basis for assessment.
Both figures matter, but they answer different questions.
A balanced way to read the data
The current data do not support a single conclusion about the entire Indian equity market.
They show a market with considerable dispersion. Healthcare has one of the largest premiums relative to its own history. Defence, pharmaceuticals, energy and infrastructure also trade above their long-term valuation levels.
Midcaps and smallcaps carry higher valuations than the Nifty 50 on several measures, while their recent earnings growth has also been stronger.
At the other end, IT, financial services and banks trade below their respective long-term valuation averages.
For an investor or analyst, the most relevant next step is therefore not to ask which sector has the highest P/E. It is to compare the current valuation with the earnings growth that the market may already expect.
That analysis can include forward P/E, expected three-year earnings growth, PEG, free-cash-flow yield, return on capital, balance-sheet strength and the gap between current valuation and historical valuation.
Such a framework can help separate a high valuation that has substantial earnings support from a high valuation that depends on unusually strong future assumptions.
The figures available as of 2026 show that healthcare carries one of the strongest historical valuation premiums, while smallcaps show a notable combination of elevated historical valuation and relatively high expected earnings growth. These are observations from the cited data rather than a conclusion about future share-price performance.
Ultimately, valuation dispersion means that the Indian equity market should not be treated as a single asset with one uniform valuation. The difference between sectors, company sizes and earnings expectations is large enough to warrant a more detailed analysis at the company level.
The most informative comparison is therefore between the price investors pay today, the earnings growth embedded in that price, and the historical valuation assigned to comparable earnings. That approach gives a clearer view of where the market places the greatest premium on future growth without assuming that the premium will necessarily persist.
ALSO READ: India’s EV Charging Gap Raises a 2030 Scale Question
